| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3357923
Max Phase: Preclinical
Molecular Formula: C8H10N4O7
Molecular Weight: 274.19
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=c1[nH]c(=O)n(COC(CO)CO)c2no[n+]([O-])c12
Standard InChI: InChI=1S/C8H10N4O7/c13-1-4(2-14)18-3-11-6-5(12(17)19-10-6)7(15)9-8(11)16/h4,13-14H,1-3H2,(H,9,15,16)
Standard InChI Key: FRIMMAMRDWFWQN-UHFFFAOYSA-N
Associated Targets(Human)
WISH 126 Activities
Associated Targets(non-human)
Vesicular stomatitis virus 4460 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 274.19 | Molecular Weight (Monoisotopic): 274.0549 | AlogP: -3.36 | #Rotatable Bonds: 5 |
| Polar Surface Area: 157.52 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 11 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 7.04 | CX Basic pKa: | CX LogP: -3.49 | CX LogD: -4.00 |
| Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.48 | Np Likeness Score: -0.17 |
References
| 1. Xu X, Wang J, Yao Q.. (2015) Synthesis and quantitative structure-activity relationship (QSAR) analysis of some novel oxadiazolo[3,4-d]pyrimidine nucleosides derivatives as antiviral agents., 25 (2): [PMID:25515560] [10.1016/j.bmcl.2014.11.065] |
Source
Source(1):